NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/02/2026
Back to search
Official data from USPTO
DAIICHI-SANKYO CANCERENTERPRISE CARE. COMPASSION. SCIENCE. IT'S OUR OBLIGATION.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
04/03/2026
Trademark type
Combined
Nice classes
42, 44
Filing date
12/14/2016
Registration date
03/06/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/20/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
JP
Examiner
TORRES, ELIANA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "DAIICHI- SANKYO" in blue, with a grey line below and the wording "CANCERENTERPRISE" below it, in green, where the wording "CANCER" is in bold green; the wording "CARE. COMPASSION. SCIENCE. IT'S OUR OBLIGATION" appears to the right in black font; there is a circle formed by a blue partial bottom and connected to an upper partial circle in green and yellow; the center of the circle is white.
Holders and representatives
Holders
DAIICHI SANKYO COMPANY, LIMITED
Representatives
Mark Lebow Ladas & Parry
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing information on clinical studies and trials of pharmaceuticals
Class 44
Providing medical information in the field of pharmaceutical preparations; providing medical information on the efficacyside effectsinteractions or administration of pharmaceutical preparations
Publications
History of USPTO decisions and trademark events.
45 publications found
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
10/18/2025
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/27/2025
INPC
INVALIDATION PROCESSED
09/27/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
05/20/2025
C71T
CANCELLED SECTION 71
09/20/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/06/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/03/2022
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
07/14/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/11/2018
FIMP
FINAL DISPOSITION PROCESSED
06/11/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/06/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
03/06/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/19/2017
PUBO
PUBLISHED FOR OPPOSITION
12/19/2017
GPNX
NOTIFICATION PROCESSED BY IB
12/15/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/29/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/29/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/29/2017
ALIE
ASSIGNED TO LIE
11/15/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/07/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
11/07/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/07/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
11/07/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/04/2017
GNRT
NON-FINAL ACTION E-MAILED
10/04/2017
CNRT
NON-FINAL ACTION WRITTEN
10/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/14/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2017
UNDR
UNDELIVERABLE MAIL - CORRESP. REMAILED
08/31/2017
RFNT
REFUSAL PROCESSED BY IB
07/01/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/15/2017
RFRR
REFUSAL PROCESSED BY MPU
06/15/2017
MAFR
APPLICATION FILING RECEIPT MAILED
06/09/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/06/2017
CNRT
NON-FINAL ACTION WRITTEN
06/05/2017
DOCK
ASSIGNED TO EXAMINER
06/05/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/05/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/18/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/18/2017
Continuous trademark protection
Get notified about every new filing that threatens DAIICHI-SANKYO CANCERENTERPRISE CARE. COMPASSION. SCIENCE. IT'S OUR OBLIGATION. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.